Cargando…

Guidance for Safety and Dosing of Medicines in Patients With Cirrhosis Is Available

Detalles Bibliográficos
Autores principales:	Weersink, Rianne A., Drenth, Joost P.H., Hunfeld, Nicole G.M., Borgsteede, Sander D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6719734/ https://www.ncbi.nlm.nih.gov/pubmed/31497748 http://dx.doi.org/10.1002/hep4.1399

Ejemplares similares

Why zolpidem increases the risk of falls and fractures in patients with cirrhosis
por: Weersink, Rianne Antoinet, et al.
Publicado: (2022)

Evaluating the safety and dosing of drugs in patients with liver cirrhosis by literature review and expert opinion
por: Weersink, Rianne A, et al.
Publicado: (2016)

Prevalence of Drug Prescriptions and Potential Safety in Patients with Cirrhosis: A Retrospective Real-World Study
por: Weersink, Rianne A., et al.
Publicado: (2018)

Safe use of proton pump inhibitors in patients with cirrhosis
por: Weersink, Rianne A., et al.
Publicado: (2018)

Evidence-Based Recommendations to Improve the Safe Use of Drugs in Patients with Liver Cirrhosis
por: Weersink, Rianne A., et al.
Publicado: (2018)

Medication safety in patients with hepatic impairment: A survey of community pharmacists' knowledge level and their practice in caring for these patients
por: Weersink, Rianne A., et al.
Publicado: (2020)

Collaboration Is Needed to Translate Pharmacology Data Into Better Health Outcomes in Chronic Liver Disease
por: Weersink, Rianne A., et al.
Publicado: (2021)

Evaluation of Information in Summaries of Product Characteristics (SmPCs) on the Use of a Medicine in Patients With Hepatic Impairment
por: Weersink, Rianne A., et al.
Publicado: (2019)

Medication-Related Problems in Liver Transplant Recipients in the Outpatient Setting: A Dutch Cohort Study
por: Mulder, Midas B., et al.
Publicado: (2021)

Accessing first doses of mpox vaccine made available in Victoria, Australia
por: Chow, Eric P.F., et al.
Publicado: (2023)

Hepatic Cirrhosis
por: Lal, Sham Mohan
Publicado: (1905)

Ascites and Cirrhosis
por: Stott, Hugh
Publicado: (1911)

Infantile Cirrhosis of the Liver
por: Iyer, L. R. Narayana
Publicado: (1927)

Infantile Cirrhosis of the Liver
por: Samuel, P. D.
Publicado: (1926)

Infantile Biliary Cirrhosis
por: Forsyth, W. Leonard
Publicado: (1937)

Infantile Cirrhosis of the Liver and Rickets
por: Iyer, A. S. Vaidyanatha
Publicado: (1928)

Rickets and Infantile Cirrhosis of the Liver
por: Gopalan, N.
Publicado: (1927)

Treatment of Infantile Cirrhosis of the Liver
por: Singh, Thakar
Publicado: (1950)

The Fourth Member of the Child Guidance Team
por: Wellisch, E.
Publicado: (1951)

Guidance for Pediatric Familial Hypercholesterolemia 2017
por: Harada-Shiba, Mariko, et al.
Publicado: (2018)

Alcohol as an Ætiological Factor in Cirrhosis of the Liver
por: Ghosh, Nishanath
Publicado: (1922)

Ritonavir and COVID-19: pragmatic guidance is important
por: Waters, Laura, et al.
Publicado: (2022)

Global Availability of Cancer Registry Data
por: Siddiqui, Asif H., et al.
Publicado: (2018)

Infantile Biliary Cirrhosis and Artificial Feeding of Infants in India
por: Gothoskar, S. B.
Publicado: (1931)

Splanchnic Vein Thrombosis in Cirrhosis − Areas Still in the Shadow
por: Gîrleanu, Irina, et al.
Publicado: (2018)

Portal Vein Thrombosis in Decompensated Cirrhosis: Rationale for Treatment
por: Senzolo, Marco, et al.
Publicado: (2019)

Antibiotic prophylaxis in palliative patients with cirrhosis: Stewardship or gatekeeping?
por: Haddadin, Yazan, et al.
Publicado: (2023)

Evaluation of medication-related problems in liver transplant recipients with and without an outpatient medication consultation by a clinical pharmacist: a cohort study
por: Mulder, Midas B., et al.
Publicado: (2022)

COVID-19 and obesity—lack of clarity, guidance, and implications for care
por: Flint, Stuart William, et al.
Publicado: (2020)

Everolimus and long acting octreotide as a volume reducing treatment of polycystic livers (ELATE): study protocol for a randomized controlled trial
por: Chrispijn, Melissa, et al.
Publicado: (2011)

A new noninvasive technique for estimating hepatic triglyceride: will liver biopsy become redundant in diagnosing non-alcoholic fatty liver disease?
por: Betzel, Bark, et al.
Publicado: (2014)

Human rhinovirus infection and cirrhosis: A potential fatal complication
por: Jacques, Jérémie, et al.
Publicado: (2015)

Reply: Antibiotic prophylaxis in palliative patients with cirrhosis: Stewardship or gatekeeping?
por: O'Brien, Alastair, et al.
Publicado: (2023)

Systematic review and critical appraisal of guidance documents for extracorporeal membrane oxygenation
por: Liang, Hanwen, et al.
Publicado: (2023)

An evaluation of the completeness of safety reporting in reports of complementary and alternative medicine trials
por: Turner, Lucy-Ann, et al.
Publicado: (2011)

Loss to follow‐up in the hepatitis C care cascade: A substantial problem but opportunity for micro‐elimination
por: van Dijk, Marleen, et al.
Publicado: (2020)

Prevention of SARS-CoV-2 infection in patients with decompensated cirrhosis
por: Xiao, Yong, et al.
Publicado: (2020)

WHO guidance to support HIV care models during the Covid-19 era
por: Ford, Nathan, et al.
Publicado: (2021)

Polycystic liver disease: an overview of pathogenesis, clinical manifestations and management
por: Cnossen, Wybrich R, et al.
Publicado: (2014)

Coronavirus disease 2019 (COVID‐19) vaccination in patients with cirrhosis: Does it work?
por: Calleri, Alberto, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_mlj1cdn5d7u4b3h2qvp97223ej